Khoobsurat Limited (KHOOBSURAT) Fair Value & Analysis
Financial Services · IN · Market cap ₹249M
Fair value as of: Jul 5, 2026
From 6 valuation models · updated today
Share price −5.4% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹0.4600 – ₹0.8200 · fair‑value band ₹0.0600 – ₹0.0700 · the ₹0.5300 price screens above the ₹0.0700 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Khoobsurat Limited (KHOOBSURAT) currently trades at ₹0.5300, while our model-based Fair Value estimate is ₹0.0700 — implying the stock looks roughly 86.8% overvalued today. We read business quality at 46/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Khoobsurat Limited generated revenue of ₹26.6M at a net margin of -17.6%. Revenue grew 84.7% year over year. It earns a return on equity of -0.8%. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹0.0600 (bear case) to ₹0.0700 (bull case); at ₹0.5300, the current price sits above that range. The share trades about 38% below its 52-week high and 20% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside — at -87%, KHOOBSURAT screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
Khoobsurat Limited engages in finance and investment business in India. It invests and trades in shares and securities. Khoobsurat Limited was incorporated in 1982 and is based in Kolkata, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Khoobsurat Limited reported revenue of ₹3.4M in FY2026 versus ₹2.0M in FY2022, a compound +14.7%/yr. Reported net income was −₹4.7M in FY2026.
Is KHOOBSURAT fairly valued? → Check now
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $4.20 | $6.41 | +53% |
| The Schiehallion Fund Limited MNTN | $0.0214 | $0.0400 | +87% |
| BlackRock, Inc BLK | 17,417 MXN | 11,340 MXN | -35% |
| BH Macro Limited BHMU | $4.42 | $8.84 | +100% |
| Blackstone Inc BX | $118.48 | $55.81 | -53% |
| Investor AB IVSBF | $39.99 | $79.98 | +100% |
| BioPharma Credit PLC BPCR | $0.0095 | $0.0200 | +111% |
| Brookfield Corporation BN | $43.94 | $9.95 | -77% |
| KKR & Co KKR | $94.45 | $26.57 | -72% |
| Brookfield Asset Management Ltd BAM | $47.29 | $23.91 | -49% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Khoobsurat Limited (KHOOBSURAT) undervalued?
What is the fair value of KHOOBSURAT?
What is the quality score of KHOOBSURAT?
What is the revenue of Khoobsurat Limited (KHOOBSURAT)?
What is the net profit margin of KHOOBSURAT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.